COM:CASTLEBIOSCIENCES
Castle Biosciences
- Stock
Last Close
28.88
22/11 21:00
Market Cap
482.57M
Beta: -
Volume Today
314.82K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|
net income | -12.37M - | -6.37M 48.53% | 5.28M 182.88% | -10.28M 294.88% | -31.29M 204.28% | -67.14M 114.55% | -57.47M 14.41% | |
depreciation and amortization | 310.82K - | 323.02K 3.92% | 358K 10.83% | 472K 31.84% | 3.41M 621.82% | 10.54M 209.45% | 12.33M 16.95% | |
deferred income tax | -163.29K - | 272.42K 266.83% | -2.28M 936.95% | 1.40M 161.27% | -8.74M 725.34% | -1.88M 78.51% | -223K 88.12% | |
stock based compensation | 108.70K - | 293.64K 170.15% | 1.25M 325.35% | 8.31M 565.25% | 21.74M 161.64% | 36.32M 67.07% | 51.22M 41.02% | |
change in working capital | -640.51K - | -7.36M 1,048.92% | 44K 100.60% | 9.15M 20,690.91% | -4.10M 144.84% | -7K 99.83% | -6.63M 94,614.29% | |
accounts receivables | -428.21K - | -8.41M 1,863.43% | -896K 89.34% | 1.66M 285.60% | -4.63M 378.47% | -6.22M 34.27% | -14.93M 140.11% | |
inventory | -115.56K - | -577.66K 399.89% | -355K 38.54% | -980K 176.06% | 327K 133.37% | -1.68M 613.76% | -3.96M 135.83% | |
accounts payables | 370.90K - | 197.25K 46.82% | 557K 182.39% | 169K 69.66% | -182K 207.69% | 582K 419.78% | 5.71M 880.58% | |
other working capital | -467.65K - | 1.43M 405.59% | 738K 48.36% | 8.30M 1,024.12% | 384K 95.37% | 7.31M 1,803.39% | 6.55M 10.32% | |
other non cash items | 520.23K - | 542.37K 4.26% | 2.37M 336.42% | 823K 65.23% | -19.50M - | 635K 103.26% | ||
net cash provided by operating activities | -12.23M - | -12.29M 0.50% | 7.01M 157.06% | 9.87M 40.63% | -18.98M 292.43% | -41.66M 119.43% | -135K 99.68% | |
investments in property plant and equipment | -494.85K - | -277.04K 44.02% | -937K 238.22% | -4.75M 407.04% | -3.48M 26.69% | -5.63M 61.70% | -13.62M 141.85% | |
acquisitions net | 3K - | -63.18M 2,106,233.33% | -26.97M 57.32% | 13K 100.05% | ||||
purchases of investments | -134.69M - | -189.07M 40.38% | ||||||
sales maturities of investments | 186.50M - | |||||||
other investing activites | 10K - | 742K 7,320% | ||||||
net cash used for investing activites | -494.85K - | -277.04K 44.02% | -937K 238.22% | -4.75M 406.72% | -66.66M 1,303.90% | -166.54M 149.85% | -16.18M 90.28% | |
debt repayment | -2M - | -1.79M - | -27.36M 1,427.58% | -8K 99.97% | -122K 1,425% | -142K 16.39% | ||
common stock issued | 65.93M - | 330.04M 400.59% | 3.90M 98.82% | 833K 78.63% | 269K 67.71% | |||
common stock repurchased | -781K - | -1.69M 116.13% | ||||||
dividends paid | -3.12M - | -1.69M 45.85% | ||||||
other financing activites | 10.87M - | 15.84M 45.75% | 24.15M 52.47% | 3.21M 86.72% | 5.43M 69.23% | 4.18M 23.01% | -2.42M 158.01% | |
net cash used provided by financing activities | 8.87M - | 15.84M 78.63% | 88.29M 457.44% | 305.89M 246.47% | 5.42M 98.23% | 1.51M 72.05% | -2.30M 251.68% | |
effect of forex changes on cash | -5.49M - | |||||||
net change in cash | -3.86M - | 3.27M 184.58% | 94.37M 2,788.95% | 311.01M 229.58% | -80.22M 125.79% | -206.69M 157.65% | -24.11M 88.34% | |
cash at beginning of period | 5.07M - | 1.21M 76.11% | 4.48M 269.54% | 98.84M 2,106.85% | 409.85M 314.64% | 329.63M 19.57% | 122.95M 62.70% | |
cash at end of period | 1.21M - | 4.48M 269.49% | 98.84M 2,107.09% | 409.85M 314.64% | 329.63M 19.57% | 122.95M 62.70% | 98.84M 19.61% | |
operating cash flow | -12.23M - | -12.29M 0.50% | 7.01M 157.06% | 9.87M 40.63% | -18.98M 292.43% | -41.66M 119.43% | -135K 99.68% | |
capital expenditure | -494.85K - | -277.04K 44.02% | -937K 238.22% | -4.75M 407.04% | -3.48M 26.69% | -5.63M 61.70% | -13.62M 141.85% | |
free cash flow | -12.73M - | -12.57M 1.23% | 6.08M 148.35% | 5.11M 15.86% | -22.47M 539.30% | -47.29M 110.48% | -13.76M 70.91% |
All numbers in USD (except ratios and percentages)